rAAV1-CB-hAAT

BIOLOGICAL2 trials

Sponsors

University of Massachusetts, Worcester, Beacon Therapeutics

Conditions

Alpha 1-Antitrypsin DeficiencyAlpha-1 Antitrypsin Deficiency

Phase 1

Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency

CompletedNCT00430768

University of Massachusetts, WorcesterAlpha 1-Antitrypsin Deficiency

Start: 2006-02-28End: 2015-01-31Updated: 2016-12-15

Phase 2

Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency

CompletedNCT01054339

Beacon TherapeuticsAlpha-1 Antitrypsin Deficiency

Start: 2010-06-30End: 2015-10-31Updated: 2019-03-28